<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940617-1-00081</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4702 -->  <!-- PJG ITAG l=21 g=1 f=1 --> (2) Horan, T.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> et al., <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  ``Pathogens  <!-- PJG 0012 frnewline --> Causing Nosocomial Infections,''  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> The  <!-- PJG 0012 frnewline --> Antimicrobic Newsletter,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> 5:65&hyph;67, 1988.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (3) Andersen, L. J., ``Major Trends in  <!-- PJG 0012 frnewline --> Nosocomial Viral Infections,''  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> The American  <!-- PJG 0012 frnewline --> Journal of Medicine,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> 91:107S&hyph;111S, 1991.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (4) Jarvis, W. R.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> et al., <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  ``Nosocomial  <!-- PJG 0012 frnewline --> Outbreaks: The Centers for Disease Control's  <!-- PJG 0012 frnewline --> Hospital Infections Program Experience,''  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> The  <!-- PJG 0012 frnewline --> American Journal of Medicine,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> 91:101S&hyph;106S,  <!-- PJG 0012 frnewline --> 1991.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (5) American Society for Testing and  <!-- PJG 0012 frnewline --> Materials, ``Standard Test Method for  <!-- PJG 0012 frnewline --> Evaluation of Health Care Personnel Handwash  <!-- PJG 0012 frnewline --> Formulation, Designation E 1174,'' in ``The  <!-- PJG 0012 frnewline --> Annual Book of ASTM Standards,'' vol. 11.04,  <!-- PJG 0012 frnewline --> American Society for Testing and Materials,  <!-- PJG 0012 frnewline --> Philadelphia, pp. 209&hyph;212, 1987.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (6) American Society for Testing and  <!-- PJG 0012 frnewline --> Materials, ``Standard Test Method for  <!-- PJG 0012 frnewline --> Evaluation of a Preoperative Skin  <!-- PJG 0012 frnewline --> Preparation, Designation E 1173,'' in ``The  <!-- PJG 0012 frnewline --> Annual Book of ASTM Standards,'' vol. 11.04,  <!-- PJG 0012 frnewline --> American Society for Testing and Materials,  <!-- PJG 0012 frnewline --> Philadelphia, pp. 205&hyph;208, 1987.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (7) American Society for Testing and  <!-- PJG 0012 frnewline --> Materials, ``Standard Test Method for  <!-- PJG 0012 frnewline --> Evaluation of Surgical Hand Scrub  <!-- PJG 0012 frnewline --> Formulation, Designation 1115,'' in ``The  <!-- PJG 0012 frnewline --> Annual Book of ASTM Standards,'' vol. 11.04,  <!-- PJG 0012 frnewline --> American Society for Testing and Materials,  <!-- PJG 0012 frnewline --> Philadelphia, pp. 201&hyph;204, 1986.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> II. The Agency's Amended Tentative Final Monograph  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> A. Summary of Ingredient Categories and  <!-- PJG 0012 frnewline --> Testing of Category II and Category III Conditions  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> 1. Summary of Ingredient Categories <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The agency has carefully reviewed the claimed active ingredients submitted to  <!-- PJG 0012 frnewline --> this administrative record (Docket No. 75N&hyph;0183), which includes  <!-- PJG 0012 frnewline --> the following: the advance notice of proposed rulemaking (39 FR  <!-- PJG 0012 frnewline --> 33103) and previous tentative final monograph (43 FR 1210) for  <!-- PJG 0012 frnewline --> OTC topical antimicrobial drug products, the advance notice of  <!-- PJG 0012 frnewline --> proposed rulemaking for OTC topical alcohol drug products (47 FR  <!-- PJG 0012 frnewline --> 22324), and the advance notice of proposed rulemaking for OTC  <!-- PJG 0012 frnewline --> topical mercury-containing drug products (47 FR 436). Based upon  <!-- PJG 0012 frnewline --> the available information, including clinical and marketing  <!-- PJG 0012 frnewline --> history, as well as the recommendations of the Miscellaneous  <!-- PJG 0012 frnewline --> External Panel, the agency is proposing a tentative  <!-- PJG 0012 frnewline --> classification for OTC health-care antiseptic active ingredients.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Many of the ingredients included in the tabulation below are  <!-- PJG 0012 frnewline --> in Category II and Category III because of no data or a lack of  <!-- PJG 0012 frnewline --> data on use as a health-care antiseptic. However, all the  <!-- PJG 0012 frnewline --> ingredients have been included as a convenience to the reader.  <!-- PJG 0012 frnewline --> The agency specifically invites comment and additional data on  <!-- PJG 0012 frnewline --> these ingredients.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> The advance notice of proposed rulemaking for alcohol drug  <!-- PJG 0012 frnewline --> products for topical antimicrobial OTC human use (47 FR 22324,  <!-- PJG 0012 frnewline --> May 21, 1982) is being incorporated into this amended tentative  <!-- PJG 0012 frnewline --> final monograph. In that proposed monograph, the Miscellaneous  <!-- PJG 0012 frnewline --> External Panel recommended that alcohol 60 to 95 percent by  <!-- PJG 0012 frnewline --> volume in an aqueous solution denatured according to Bureau of  <!-- PJG 0012 frnewline --> Alcohol, Tobacco, and Firearms regulations at 27 CFR part 21 and  <!-- PJG 0012 frnewline --> isopropyl alcohol 50 to 91.3 percent by volume in an aqueous  <!-- PJG 0012 frnewline --> solution be classified as Category I for topical antimicrobial  <!-- PJG 0012 frnewline --> use. The following indications were proposed:  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (1) ``For first aid use to decrease germs in minor cuts and  <!-- PJG 0012 frnewline --> scrapes.''  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (2) ``To decrease germs on the skin prior to removing a  <!-- PJG 0012 frnewline --> splinter or other foreign object.''  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (3) ``For preparation of the skin prior to an injection.''  <!-- PJG 0012 frnewline --> (See the advance notice of proposed rulemaking for OTC alcohol  <!-- PJG 0012 frnewline --> drug products for topical antimicrobial use, in the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=4 --> Federal  <!-- PJG 0012 frnewline --> Register  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> of May 21, 1982, 47 FR 22324.)  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Based upon submitted data and the conclusions of the  <!-- PJG 0012 frnewline --> Miscellaneous External Panel, the agency is including alcohol as  <!-- PJG 0012 frnewline --> a Category I surgical hand scrub, patient preoperative skin  <!-- PJG 0012 frnewline --> preparation, and antiseptic handwash or health-care personnel  <!-- PJG 0012 frnewline --> handwash (see section I.E., comment 10). While no comments  <!-- PJG 0012 frnewline --> submitted data on health-care uses of isopropyl alcohol, the  <!-- PJG 0012 frnewline --> agency notes that one comment (Ref. 1) from a manufacturer  <!-- PJG 0012 frnewline --> requested that the OTC alcohol drug products monograph provide  <!-- PJG 0012 frnewline --> the labeling indication, ``antibacterial handwash.'' The same  <!-- PJG 0012 frnewline --> manufacturer provided a submission (Ref. 2) to the Miscellaneous  <!-- PJG 0012 frnewline --> External Panel on a combination product containing isopropyl  <!-- PJG 0012 frnewline --> alcohol 50 percent and oxyquinoline sulfate 0.125 percent for use  <!-- PJG 0012 frnewline --> as a germicidal-fungicidal wash. However, the Panel disbanded  <!-- PJG 0012 frnewline --> before it was able to review the submission, which contained  <!-- PJG 0012 frnewline --> labeling for a currently marketed product and in vitro studies of  <!-- PJG 0012 frnewline --> the product's bacteriocidal activity. No in vivo effectiveness  <!-- PJG 0012 frnewline --> data were submitted for the use of isopropyl alcohol as an  <!-- PJG 0012 frnewline --> antiseptic handwash or health-care personnel handwash, patient  <!-- PJG 0012 frnewline --> preoperative skin preparation, or surgical hand scrub.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Based on the lack of data for the use of isopropyl alcohol  <!-- PJG 0012 frnewline --> as an antiseptic handwash or health-care personnel handwash and  <!-- PJG 0012 frnewline --> surgical hand scrub, the agency is placing the ingredient in  <!-- PJG 0012 frnewline --> Category III for these uses. The agency invites data on these  <!-- PJG 0012 frnewline --> uses of isopropyl alcohol. As discussed in section I.E., comment  <!-- PJG 0012 frnewline --> 10, the agency is including the Panel's recommended indication  <!-- PJG 0012 frnewline --> ``for the preparation of the skin prior to an injection'' as an  <!-- PJG 0012 frnewline --> additional Category I indication for patient preoperative skin  <!-- PJG 0012 frnewline --> preparations containing alcohol. Based on the Panel's  <!-- PJG 0012 frnewline --> recommendations, the agency is also proposing isopropyl alcohol  <!-- PJG 0012 frnewline --> as a Category I patient preoperative skin preparation for this  <!-- PJG 0012 frnewline --> indication. However, based on the lack of data on the use of  <!-- PJG 0012 frnewline --> isopropyl alcohol for more general patient preoperative skin  <!-- PJG 0012 frnewline --> preparation use, the agency is not proposing isopropyl alcohol as  <!-- PJG 0012 frnewline --> Category I for the other patient preoperative skin preparation  <!-- PJG 0012 frnewline --> indications included in &sect;333.460(b)(1),  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> i.e., <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  ``for the  <!-- PJG 0012 frnewline --> preparation of the skin prior to surgery'' and ``helps to reduce  <!-- PJG 0012 frnewline --> bacteria that potentially can cause skin infection.''  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            